BCRX

MKT CAP:$2B

BioCryst Pharmaceuticals Inc

Market Cap

$2B

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$8.43+$0.93 (+12.40%)

Jun 8, 2026

52W High $11.1152W Low $6.24

Company Details

BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for t...

CEO

—

IPO Date

Mar 3, 1994

Website

www.biocryst.com

Key Metrics TTM

Revenue

$886M

+75.9% YoY

Net Income

-$458M

EPS (Diluted)

Free Cash Flow

$294M

Revenue / Share

$3.66

Gross Margin

18.9%

Operating Margin

-43.1%

Net Margin

-51.7%

FCF Margin

33.1%

P/S

2.4x

P/E

Earnings Reports

Q2 2026

Aug 3, 2026

PENDING

Q1 2026

May 6, 2026

$156M+7.5%

FY 2025

Feb 26, 2026

$875M+94.1%

Q4 2025

Feb 26, 2026

$407M+209.1%

Q3 2025

Nov 4, 2025

$159M+36.1%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee